Searchicon: search
Sort by
icon: arrow-right

News Releases

Merck Animal Health Announces FDA Approval of EXZOLT™ (fluralaner oral solution) for Chickens, the First Systemic Treatment for Northern Fowl Mites

Innovative oral solution offers a safe and effective approach to combat northern fowl mite infestations in poultry RAHWAY, N.J., July 18, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and

icon: arrow-right

News Releases

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

RAHWAY, N.J., July 10, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug

icon: arrow-right

Featured Stories

Big data can carry farming forward. Now more than ever, farmers must embrace it.

To most Americans, farmers remain unseen figures behind the food on their dinner tables — hand-written records, calloused hands, and long days of physical labor.

icon: arrow-right

News Releases

Merck Animal Health Receives Positive Opinion from CVMP for NOBIVAC®L6 and NOBIVAC® LoVo L6 Vaccines for Use in Dogs Against Leptospirosis

RAHWAY, N.J., June 12, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBIVAC® L6 and NOBIVAC®

icon: arrow-right

News Releases

Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs 

If Approved, NUMELVI Will Be the First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Treatment of Pruritus Associated with Allergic Dermatitis Including Atopic Dermatitis and Treatment of Clinical Manifestations of Atopic Dermatitis in Dogs RAHWAY, N.J., June 12, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States

icon: arrow-right

News Releases

Merck Animal Health Receives Positive CVMP Opinion for INNOVAX®-ND-IBD-ILT for Use in Chickens

RAHWAY, NJ, May 16, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the INNOVAX®-ND-IBD-ILT vaccine.

icon: arrow-right

News Releases

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

Merck Animal Health unveils its largest economic development project in recent history Rahway, NJ, May 8, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and Kansas Governor Laura Kelly jointly announced today the $895

icon: arrow-right

News Releases

FDA Approves Merck Animal Health’s MOMETAMAX SINGLE™ to Treat Otitis Externa in Dogs

The leading manufacturer of otic treatments expands portfolio with the only FDA-approved, one dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens RAHWAY, N.J., May 02, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced

icon: arrow-right

News Releases

Merck Animal Health Announces the European Approval of NOBILIS MULTRIVA™ REOm for Use in Chickens 

New vaccine reduces viraemia and clinical signs of disease caused by avian reovirus, expanding NOBILIS MULTRIVA portfolio RAHWAY, N.J., March 27, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that the European Commission has

icon: arrow-right

Featured Stories

Evolving Customer Relationships With Subscriptions

Subscription-based business models are changing industries from movies to media to software, and they’re altering animal health, too.

icon: arrow-right

News Releases

Expert tips for preventing spring respiratory disease outbreaks

Expert tips for preventing spring respiratory disease outbreaks RAHWAY, N.J., February 11, 2025 – As winter transitions to spring, horse owners and barn managers should be on alert for equine influenza (EIV), a highly contagious respiratory disease that has historically surged during this time of year (see figure 1). Recent biosurveillance data underscores this seasonal

icon: arrow-right

News Releases

Merck Animal Health’s Laurie Hueneke Martens Receives “Feather in Her Cap” Award for Contributions to the Animal Health Industry

RAHWAY, N.J., Jan. 30, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that Laurie Hueneke Martens, associate vice president, Global Public Policy and Government Relations, was awarded the 8th Annual Feather in Her

Previous Next